Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01MVO
|
|||
| Former ID |
DNCL001686
|
|||
| Drug Name |
ARG201
|
|||
| Indication | Diffuse systemic sclerosis [ICD-11: 4A42.1; ICD-10: M34.0] | Phase 2 | [1] | |
| Systemic sclerosis [ICD-11: 4A42; ICD-9: 710.1] | Phase 2 | [2], [3] | ||
| Company |
ArGentis Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026882) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.